Mark L. Baum

Chief Executive Officer
Member, Board of Directors

Mark L. Baum has more than 15 years experience in financing, operating and advising small capitalization publicly traded enterprises, with a particular focus on restructured or reorganized businesses. 

read more »

Andrew R. Boll

Vice-President, Accounting & Public Reporting

Mr. Boll, has over eight years of experience in financial reporting and accounting with a significant portion of that experience working with small capitalization companies, with a particular focus on restructured and reorganized businesses.

read more »

Gary Seelhorst

Vice-President, Corporate Development

Mr. Seelhorst, has over 17 years of clinical and corporate development experience with both large-cap pharmaceutical companies (e.g. Eli Lilly and Pfizer) as well as start-up ventures including extensive capital raising, licensing, and M&A transactions.

read more »

Jeannette V. Filippone

General Counsel

Jeannette V. Filippone has served as Chief Legal Officer and General Counsel of Imprimis Pharmaceuticals since April 2013. From September 2003 to April 2013, she served as a corporate attorney with the San Diego office of Morrison & Foerster LLP, where her practice focused on securities offerings and regulation, mergers and acquisitions, corporate governance and other corporate matters.

read more »

Victor Repkin

Intellectual Property Analyst

Victor Repkin, Ph.D., has served as patent attorney and intellectual property analyst for Imprimis Pharmaceuticals since June 2013.  Dr. Repkin has more than 15 years of experience in patent preparation and prosecution, patent counseling and due diligence.

read more »